Moreover, the presence of ASS1 in tumour cells correlated with a better prognosis in NSCLC patients, especially when cancer-associated fibroblasts (CAFs) did not express arginase-2 (ARG2) [192]. The gene discussed is ASS1; the disease is non-small cell lung carcinoma.